Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Alternatives to Consider

  • SciSure Reviews & Ratings
    311 Ratings
    Company Website
  • Qloo Reviews & Ratings
    23 Ratings
    Company Website
  • AlisQI Reviews & Ratings
    108 Ratings
    Company Website
  • RaimaDB Reviews & Ratings
    12 Ratings
    Company Website
  • AnalyticsCreator Reviews & Ratings
    46 Ratings
    Company Website
  • Curbside Laundries Reviews & Ratings
    63 Ratings
    Company Website
  • Hyperproof Reviews & Ratings
    350 Ratings
    Company Website
  • IONOS Cloud GPU Servers Reviews & Ratings
    45,340 Ratings
    Company Website
  • Wash-Dry-Fold POS Reviews & Ratings
    128 Ratings
    Company Website
  • Careerminds Reviews & Ratings
    46 Ratings
    Company Website

What is NVIDIA BioNeMo?

BioNeMo is a cloud-based platform designed for drug discovery that harnesses artificial intelligence and employs NVIDIA NeMo Megatron to enable the training and deployment of large biomolecular transformer models at an impressive scale. This service provides users with access to pre-trained large language models (LLMs) and supports multiple file formats pertinent to proteins, DNA, RNA, and chemistry, while also offering data loaders for SMILES to represent molecular structures and FASTA for sequences of amino acids and nucleotides. In addition, users have the flexibility to download the BioNeMo framework for local execution on their own machines. Among the notable models available are ESM-1, which is based on Meta AI’s state-of-the-art ESM-1b, and ProtT5, both fine-tuned transformer models aimed at protein language tasks that assist in generating learned embeddings for predicting protein structures and properties. Furthermore, the platform will incorporate OpenFold, an innovative deep learning model specifically focused on forecasting the 3D structures of new protein sequences, which significantly boosts its capabilities in biomolecular exploration. Overall, this extensive array of tools establishes BioNeMo as an invaluable asset for researchers navigating the complexities of drug discovery in modern science. As such, BioNeMo not only streamlines research processes but also empowers scientists to make significant advancements in the field.

What is BenevolentAI?

BenevolentAI is a groundbreaking platform that harnesses the power of artificial intelligence and advanced scientific methodologies to improve the drug discovery process, particularly for challenging diseases, by swiftly analyzing and interpreting vast amounts of biomedical data to generate practical insights more quickly than traditional methods. Through its distinctive Benevolent Platform, the company adeptly combines both structured and unstructured biomedical data—including literature, genomic information, clinical records, and multi-omics—into a comprehensive knowledge graph. This sophisticated structure enables researchers to explore biological systems, develop testable hypotheses, discover new drug targets, and design potential drug candidates with greater assurance and lower chances of failure, thereby revolutionizing the field of medicine development. By pioneering such innovative strategies, BenevolentAI not only enhances the efficiency of pharmaceutical research but also significantly impacts the future of healthcare and treatment options. As a result, BenevolentAI is positioned as a leader in ushering in a transformative phase within the pharmaceutical sector.

Media

Media

Integrations Supported

Evo 2
NVIDIA AI Foundations
NVIDIA Clara
NVIDIA NeMo Megatron

Integrations Supported

API Availability

API Availability

Pricing Information

Pricing not provided

Pricing Information

Pricing not provided

Supported Platforms

SaaS

Supported Platforms

SaaS

Customer Service / Support

Standard Support
Web-Based Support

Customer Service / Support

Standard Support
Web-Based Support

Training Options

Documentation Hub
Webinars

Training Options

Documentation Hub
Online Training

Company Facts

Organization Name

NVIDIA

Date Founded

1993

Company Location

United States

Company Website

www.nvidia.com/en-us/gpu-cloud/bionemo/

Company Facts

Organization Name

BenevolentAI

Date Founded

2013

Company Location

Luxembourg

Company Website

www.benevolent.com

Categories and Features

AI Science

Not specified

Drug Discovery

Not specified

Healthcare AI

Not specified

Categories and Features

AI Science

Not specified

Drug Discovery

Not specified

Life Sciences

Not specified

Popular Alternatives

Popular Alternatives

ESMFold2 Reviews & Ratings

ESMFold2

Biohub
Evo 2 Reviews & Ratings

Evo 2

Arc Institute
Scitara DLX Reviews & Ratings

Scitara DLX

Scitara